“IS IT TIME FOR PCSK9 INHIBITOR TO BE USED AS STANDARD OF CARE FOR CARDIAC PATIENTS? – AN ASIAN PERSPECTIVE” BY DR JEREMY CHOW

Share the Post:

Professional Heart & Vascular Services

Search Our Tag Cloud

Blog (5)

ASM (3)

CME Webinar (2)

Events (1)

GP Talks (3)

Health Care Providers (8)

Patients & Public (27)

Resources (14)

Browse Our Categories

SIGN UP FOR OUR EMAIL NEWSLETTER

Stay informed by signing up for the Morning Briefing and other emails:

Related Articles

Are You at Risk for Heart Disease? Common Investigations You Should Know!

Patients & Public

BUBBLE CONTRAST TRANSCRANIAL DOPPLER TCD, TEST TO IDENTIFY PATENT FORAMEN OVALE TO REDUCE RECURRENCE OF STROKE

Patients & Public

WHAT EVERY WOMEN NEEDS TO KNOW ABOUT HEART DISEASE

GP Talks, Health Care Providers, Resources

TREATING CHOLESTEROL IN ASIAN PATIENTS: BALANCING THE RISK AND BENEFITS

Events, Patients & Public

HEART TO HEART TALK 2023

Patients & Public, Resources

WHAT IS TRICVALVE?

Health Care Providers, Resources

ASM AUGUST 2022

Patients & Public

LEAKING MITRAL HEART VALVE